EUVIMEDEUVIMED entdecken
EvaluationsstudieVergleichsstudie

Evaluation of the VIDAS Cytomegalovirus (CMV)‐IGRA for Assessing CMV‐Specific T‐Cell Responses in Immunocompetent and Immunosuppressed Individuals

Estela Giménez, Eliseo Albert, Ester Colomer, Ariadna Pérez, Marco Montomoli, José Luis Piñana iD, Irina Sanchis, José Luis Górriz, Carlos Solano, David Navarro iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70355 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Estela Giménez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, Interferon-gamma Release Tests, Immunocompromised Host. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: This research received private financial support from Biomerieux (Marcy l'Etoile, France)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We compared the performance of the VIDAS Cytomegalovirus (CMV)‐Interferon‐gamma release assay (IGRA) with that of laboratory‐developed flow cytometry for intracellular cytokine staining (FC‐ICS) for the assessment of CMV‐specific interferon‐gamma (IFN‐γ)‐producing T‐cell responses (CMV‐CMI). A total of 147 blood specimens from 78 adult participants were collected: 11 healthy controls, 34 hematological patients (HP), of which 32 had undergone allogeneic hematopoietic cell transplantation (allo‐HCT), and 33 Kidney transplant recipients. Of the 147 specimens, 96 tested positive, 24 negative, 25 indeterminate, and 2 were invalid by the VIDAS CMV IGRA. A total of 137 specimens were tested by FC‐ICS, of which 107 returned positive results. There were 27 discrepancies across the assays among specimens yielding interpretable results, of which 14 tested VIDAS CMV IGRA‐positive/FC‐ICS‐negative and 12 VIDAS CMV IGRA‐negative/FC‐ICS‐positive. The overall agreement between immunoassays was 78%, and the Kappa coefficient was 0.34 (0.52 for HP). Differences in identifying CMV‐infected (CMV IgG‐positive) and uninfected participants (CMV IgG‐negative) were noticed across both assays. The overall correlation (rho values) between IFN‐γ concentrations (IU/ml) measured by the VIDAS CMV IGRA and CMV‐specific IFN‐γ‐producing T‐cell frequencies were 0.27 for CD4 + and 0.33 for CD8 + T cells ( p = 0.001). In HP, the correlation was stronger (0.48 for CD4 + and 0.49 for CD8 + T cells). In summary, our data lend support to the potential utility of the VIDAS CMV IGRA to assess CMV‐CMI in transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsCytomegalovirusInterferon-gamma Release TestsImmunocompromised HostT-LymphocytesHumansAdultMiddle AgedMaleFemaleFlow CytometryAgedInterferon-gammaYoung AdultCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

T‐cell immunityVIDAS Cytomegalovirus (CMV)‐Interferon‐gamma release assay (IGRA)cytomegalovirusflow cytometry for intracellular stainingtransplant recipients

Substanzen

Interferon-gamma

Autor:innen und Institutionen

  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Hematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Nephrology Service, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, RICORS 2040 RENAL, ISCIII, Valencia, Spain.
  • Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Department of Microbiology School of Medicine, University of Valencia, Valencia, Spain.

ORCID-Profile: José Luis Piñana, David Navarro

Förderung

  • This research received private financial support from Biomerieux (Marcy l'Etoile, France).

Zitieren

APA

Giménez, E., Albert, E., Colomer, E., Pérez, A., Montomoli, M., Piñana, J. L., Sanchis, I., Górriz, J. L., Solano, C., & Navarro, D. (2025). Evaluation of the VIDAS Cytomegalovirus (CMV)‐IGRA for Assessing CMV‐Specific T‐Cell Responses in Immunocompetent and Immunosuppressed Individuals. Journal of Medical Virology. https://doi.org/10.1002/jmv.70355

Vancouver

Giménez E, Albert E, Colomer E, Pérez A, Montomoli M, Piñana JL, et al. Evaluation of the VIDAS Cytomegalovirus (CMV)‐IGRA for Assessing CMV‐Specific T‐Cell Responses in Immunocompetent and Immunosuppressed Individuals. Journal of Medical Virology. 2025. doi:10.1002/jmv.70355

BibTeX
@article{Gimnez2025,
  author = {Giménez, Estela and Albert, Eliseo and Colomer, Ester and Pérez, Ariadna and Montomoli, Marco and Piñana, José Luis and Sanchis, Irina and Górriz, José Luis and Solano, Carlos and Navarro, David},
  title = {Evaluation of the VIDAS Cytomegalovirus (CMV)‐IGRA for Assessing CMV‐Specific T‐Cell Responses in Immunocompetent and Immunosuppressed Individuals},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70355}
}
Kostenlos starten →